SHRX Stock Overview

A biology technology company, develops medicines specific for genetic diseases. More details

SHRX fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Shares are highly illiquid

Makes less than USD$1m in revenue (CA$0)

Does not have a meaningful market cap (CA$62M)

My Notes

Capture your thoughts, links and company narrative

Sharp Therapeutics Corp. Competitors

Onco-Innovations

CNSX:ONCO

CA$63.3m

Microbix Biosystems

TSX:MBX

CA$59.7m

Covalon Technologies

TSXV:COV

CA$86.6m

Oncolytics Biotech

TSX:ONC

CA$89.0m

Price History & Performance

Summary of share price highs, lows and changes for Sharp Therapeutics
Historical stock prices
Current Share Price	CA$0.22
52 Week High	CA$0.22
52 Week Low	CA$0.22
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	SHRX	CA Biotechs	CA Market
7D	n/a	3.6%	1.2%
1Y	n/a	15.1%	17.2%

Return vs Industry: Insufficient data to determine how SHRX performed against the Canadian Biotechs industry.

Return vs Market: Insufficient data to determine how SHRX performed against the Canadian Market.

Price Volatility

Is SHRX's price volatile compared to industry and market?
SHRX volatility
SHRX Average Weekly Movement	n/a
Biotechs Industry Average Movement	12.9%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	18.6%
10% least volatile stocks in CA Market	2.9%

Stable Share Price: SHRX's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: Insufficient data to determine SHRX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Scott Sneddon	www.sharptx.com

Sharp Therapeutics Corp., a biology technology company, develops medicines specific for genetic diseases. It engages in the development of the CoreX biology, AlloChem chemistry, and Disco/Mine computational technologies to discover drugs that activate the protein altered by gene mutation. Sharp Therapeutics Corp. is based in Pittsburgh, Pennsylvania.

Sharp Therapeutics Corp. Fundamentals Summary

How do Sharp Therapeutics's earnings and revenue compare to its market cap?
SHRX fundamental statistics
Market cap	CA$62.09m
Earnings (TTM)	-CA$323.58k
Revenue (TTM)	n/a

0.0x

P/S Ratio

-191.9x

P/E Ratio

Is SHRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SHRX income statement (TTM)
Revenue	CA$0
Cost of Revenue	CA$0
Gross Profit	CA$0
Other Expenses	CA$323.58k
Earnings	-CA$323.58k

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0011
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0%

How did SHRX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/20 08:43
End of Day Share Price	2025/01/17 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sharp Therapeutics Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution